STOCK TITAN

Equillium (EQ) COO exercises options and sells 95,833 common shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Equillium, Inc. senior vice president and COO Christine Zedelmayer reported a set of option exercises paired with open-market sales of common stock. She exercised employee stock options to acquire 95,833 shares at strike prices between $0.73 and $0.785 per share, then sold 95,833 shares at market prices around the high $2 range. After these transactions, she directly holds 62,586 shares of Equillium common stock. A footnote states that at least part of the sales were made under a pre-arranged Rule 10b5-1 trading plan, indicating they were scheduled in advance.

Positive

  • None.

Negative

  • None.
Insider Zedelmayer Christine
Role Sr. Vice President and COO
Sold 95,833 shs ($267K)
Type Security Shares Price Value
Exercise Employee Stock Option (right to buy) 7,292 $0.00 --
Exercise Employee Stock Option (right to buy) 48,512 $0.00 --
Exercise Employee Stock Option (right to buy) 14,583 $0.00 --
Exercise Employee Stock Option (right to buy) 15,625 $0.00 --
Exercise Common Stock 7,292 $0.73 $5K
Exercise Common Stock 48,512 $0.77 $37K
Sale Common Stock 55,604 $2.70 $150K
Sale Common Stock 200 $2.71 $542.00
Exercise Common Stock 14,583 $0.785 $11K
Exercise Common Stock 15,625 $0.785 $12K
Sale Common Stock 30,208 $2.98 $90K
Exercise Employee Stock Option (right to buy) 9,821 $0.00 --
Exercise Common Stock 9,821 $0.77 $8K
Sale Common Stock 9,821 $2.70 $27K
Holdings After Transaction: Employee Stock Option (right to buy) — 91,146 shares (Direct, null); Common Stock — 69,878 shares (Direct, null)
Footnotes (1)
  1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 27, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.97 to $3.04, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years.
Shares sold 95,833 shares Total open-market sales reported across Form 4
Shares exercised 95,833 shares Total shares acquired via option exercises
Post-transaction holdings 62,586 shares Common stock directly held after latest trades
Sale price example <money>$2.70</money> per share One of the reported transaction prices for common stock sales
Weighted average price range <money>$2.97–$3.04</money> Range for sales underlying a weighted average price disclosure
Option strike price <money>$0.785</money> per share Exercise price for certain employee stock options
Option strike price <money>$0.770</money> per share Exercise price for another option grant
Option strike price <money>$0.730</money> per share Exercise price for additional options exercised
Rule 10b5-1 trading plan financial
"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Employee Stock Option (right to buy) financial
"Employee Stock Option (right to buy) ... underlying security title Common Stock ... exercise or conversion of derivative security"
derivative security financial
"transaction_code_description Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
open-market sale financial
"transaction_action open-market sale ... transaction_code_description Sale in open market or private transaction"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Zedelmayer Christine

(Last)(First)(Middle)
2223 AVENIDA DE LA PLAYA, SUITE 105

(Street)
LA JOLLA CALIFORNIA 92037

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Equillium, Inc. [ EQ ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Sr. Vice President and COO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/27/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/27/2026M9,821A$0.7772,407D
Common Stock05/27/2026S(1)9,821D$2.762,586D
Common Stock05/28/2026M7,292A$0.7369,878D
Common Stock05/28/2026M48,512A$0.77118,390D
Common Stock05/28/2026S(1)55,604D$2.762,786D
Common Stock05/28/2026S(1)200D$2.7162,586D
Common Stock05/28/2026M14,583A$0.78577,169D
Common Stock05/28/2026M15,625A$0.78592,794D
Common Stock05/28/2026S(1)30,208D$2.98(2)62,586D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Employee Stock Option (right to buy)$0.7705/27/2026M9,821 (3)01/01/2035Common Stock9,821$0165,179D
Employee Stock Option (right to buy)$0.7305/28/2026M7,292 (3)01/01/2034Common Stock7,292$091,146D
Employee Stock Option (right to buy)$0.7705/28/2026M48,512 (3)01/01/2035Common Stock48,512$0116,667D
Employee Stock Option (right to buy)$0.78505/28/2026M14,583 (3)01/02/2033Common Stock14,583$040,105D
Employee Stock Option (right to buy)$0.78505/28/2026M15,625 (3)01/18/2032Common Stock15,625$00D
Explanation of Responses:
1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 27, 2025.
2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.97 to $3.04, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
3. Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years.
/s/ Christine Zedelmayer05/29/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Equillium (EQ) executive Christine Zedelmayer report in this Form 4?

Christine Zedelmayer reported exercising employee stock options and selling Equillium common shares. She exercised 95,833 shares via options and sold 95,833 shares in open-market transactions over two days, while retaining a remaining direct stake in the company.

How many Equillium (EQ) shares did Christine Zedelmayer sell and at what prices?

She sold a total of 95,833 shares of Equillium common stock. Individual sales occurred at prices including $2.70, $2.71, and a weighted average around $2.98, with some trades in a range from $2.97 to $3.04.

How many Equillium (EQ) shares does Christine Zedelmayer hold after these transactions?

Following the reported option exercises and sales, Christine Zedelmayer directly holds 62,586 shares of Equillium common stock. This figure comes from the post-transaction ownership column, which lists her remaining direct holdings after the most recent reported trades.

Were Christine Zedelmayer’s Equillium (EQ) stock sales pre-planned under a Rule 10b5-1 plan?

Yes. A footnote states the reported sale was effected under a Rule 10b5-1 trading plan. The plan was adopted on August 27, 2025, indicating the trades were scheduled in advance rather than made on an ad hoc basis.

What option exercises did Christine Zedelmayer report for Equillium (EQ)?

She exercised employee stock options covering 95,833 underlying shares of Equillium common stock. These options had exercise prices of $0.73, $0.77, and $0.785 per share, converting derivative awards into directly held shares before subsequent sales.

How many total Equillium (EQ) shares were involved across Christine Zedelmayer’s Form 4 transactions?

Across all transactions, she exercised options for 95,833 shares and sold 95,833 shares. The filing’s summary notes a net-sell direction based on share counts, even though the activity combines both option exercises and open-market sales.